Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

solution

solution is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 1,520
News articles 2
Drug details — solution
Class
—
Route
—
Patents
20
Programs
1520
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

solution is an FDA-listed pharmaceutical active ingredient.

Key facts

INN solution

Approval history

Authority Status Date
NMPA clinical trials —

Recent coverage

View all news
BBSW AI Solution: Key Insights from the 2026 Event
High impact AnalysisMay 21, 2026

BBSW AI Solution: Key Insights from the 2026 Event

2 min

The BBSW AI Solution event in Foster, USA, promises to unveil critical advancements in AI technology for the pharma industry. Stay tuned for live updates and key takeaways.

Dr. Sarah Mitchell
BBSW AI Solution 2026: Key Insights and Highlights
High impact AnalysisMay 21, 2026

BBSW AI Solution 2026: Key Insights and Highlights

2 min

The BBSW AI Solution event in 2026 is set to unveil groundbreaking advancements in AI technology. Join us for live coverage and key insights from industry leaders.

Dr. Sarah Mitchell

Pipeline programs

Browse pipeline
  1. 0.05% Voclosporin Ophthalmic Solution (VOS) Phase 3 · Aurinia Pharmaceuticals · Dry Eye Syndrome
  2. 0.9% Sodium Chloride Solution, Glenzocimab Phase 3 · PARItec · Acute ischemic stroke
  3. 000434 Phase 3 · Ferring Pharmaceuticals · High-risk Bacillus Calmette-Guerin (BCG)-unresponsive non-mu
  4. 042011 Phase 3 · George Institute for · Langerhans Cell Histiocytosis
  5. 071102 Phase 3 · Baxalta Innovations · Hereditary severe von Willebrand Disease in children
  6. 100-006 Phase 3 · Cardiol Therapeutics · Recurrent Pericarditis
  7. 1001 Phase 3 · Biotest Farmaceutica Ltda · Non-severe community-acquired pneumonia (CAP) or moderate or
  8. 105MS306 Phase 3 · Biogen · Relapsing Remitting Multiple Sclerosis (RRMS)

Related patents

Browse patents

  1. US 12403090

    Oral film compositions and dosage forms having precise active dissolution profiles

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12290597

    Oral film compositions and dosage forms having precise active dissolution profiles

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2025051711

    TRAITEMENT PAR PTH D'UNE MALADIE RÉNALE CHRONIQUE

    Expires Wed Mar 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12023410

    Micro/nanobubble solutions for tissue preservation and generation thereof

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11992555

    Solid solution compositions and use in chronic inflammation

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. WO 2024094673

    RÉGIME DE TRAITEMENT À BASE DE PTH COMPRENANT DEUX COMPOSÉS PTH

    Expires Thu May 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11918654

    Solid solution compositions and use in severe pain

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11896417

    Time-varying kinetic modeling of high temporal-resolution dynamic pet data for multiparametric imaging

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11873350

    Dissolution of oxidized cellulose

    Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11872244

    Thixotropic oxidized cellulose solutions and medical applications thereof

    Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11844773

    Solid solution compositions and use in chronic inflammation

    Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11752223

    Method for producing Ac-225 solution and method for producing medicine using Ac-225 solution

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. CA 3230895

    TRAITEMENTS AVEC DES COMPOSES PTH A ACTION PROLONGEE

    Expires Wed Mar 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11594302

    High resolution allele identification

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. CA 3217274

    PROCEDE DE FABRICATION D'UNE SOLUTION D'UN COMPLEXE DE GADOLINIUM

    Expires Wed Jan 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11541002

    Oral film compositions and dosage forms having precise active dissolution profiles

    Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11433038

    High concentration medicant solutions for treating neurological disorders

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. CA 3192772

    AMELIORATION DU BIEN-ETRE PHYSIQUE ET MENTAL DE PATIENTS ATTEINTS D'HYPOPARATHYROIDISME

    Expires Wed Mar 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11285163

    Ophthalmic solution

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11224659

    Solid solution compositions and use in severe pain

    Expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is solution?

solution is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.